Afb Antibiotic Sensitivity – Maxi Floxacin

2,500.00

The AFB Antibiotic Sensitivity – Maxi Floxacin test evaluates the susceptibility of Mycobacterium tuberculosis to Maxi Floxacin, a fluoroquinolone-class antibiotic. This test determines whether the tuberculosis bacteria are sensitive or resistant to Maxi Floxacin, helping guide effective treatment, especially in cases of drug-resistant tuberculosis.

Description

Why It’s Done:

• To identify if Mycobacterium tuberculosis responds to Maxi Floxacin treatment.
• To assist in managing multidrug-resistant tuberculosis (MDR-TB) or extensively drug-resistant tuberculosis (XDR-TB).
• To ensure the use of effective antibiotics for better treatment outcomes.
• To prevent the spread of drug-resistant tuberculosis strains.

Preparation:

• No special preparation is typically required.
• The test is performed on clinical samples such as sputum or tissue collected from the patient.
• Follow your healthcare provider’s instructions for sample collection.
• Inform the laboratory if you are currently on tuberculosis medication, as this may affect test results.